PCM
CELG

Poehling Capital Management’s Celgene Corp CELG Stock Holding History

Poehling Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-600
Closed -$48K – 305
2018
Q2 		$48K Sell
600
-185
-24% -$15.4K 0.04% 156
2018
Q1 		$70K Sell
785
-200
-20% -$19.2K 0.06% 127
2017
Q4 		$103K Buy
+985
New +$111K 0.09% 113

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Poehling Capital Management's CELG Position: Q3 2018 in Review

Poehling Capital Management sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 600 shares — an estimated $48K sold.

Poehling Capital Management first reported a position in CELG in Q4 2017 and held it in 3 quarters. The position peaked at $103K in Q4 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Poehling Capital Management reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Poehling Capital Management sold 600 Celgene Corp shares in Q3 2018, an estimated $48K.
  • Poehling Capital Management first reported a position in Celgene Corp in Q4 2017 and held it in 3 quarters.
  • Poehling Capital Management's Celgene Corp position peaked at $103K in Q4 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Poehling Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.